Children are particularly vulnerable to TB, and pediatric forms of the disease are especially difficult to diagnose and treat. In Dushanbe, we support the Ministry of Health to provide pediatric and family TB care, focusing on drug-resistant TB (DR-TB).
Our innovative and person-centered model of care includes tracing and testing contacts, providing child-friendly formulations, implementing new drugs, shortened regimens, and strategies to improve adherence such as family-provided directly observed therapy, a practice whereby a family member watches the patient take each dose of their medication.
In 2019, 40 of the 46 pediatric patients started on DR-TB treatment in Dushanbe benefited from injection-free regimens. The remaining six patients stopped injections within the first months of treatment to follow all-oral regimens. By the end of the year, 77 patients, including 49 children, three of whom were on treatment before 2019, we're continuing with treatment. The majority (96 percent) were being treated with newer drugs.
We plan to hand over our medical activities at the HIV project we run in Kulob district to the Ministry of Health by March 2020. The project successfully brought attention to pediatric HIV, especially nosocomial modes of transmission.
In early 2019, 110,040 schoolchildren (or their parents) consented to HIV testing at schools in Dushanbe as well as Kulob. Twenty of the 80 newly identified patients were from Kulob and subsequently started antiretroviral treatment. MSF has implemented the practice of HIV status disclosure to the children and by the end of 2019, more than 80 per cent of the children in the cohort have had their status disclosed.
No. staff in 2019: 112 | Expenditure in 2019: €2.7 million Year MSF first worked in the country: 1997
- Try a different country, year, format, or topic.
- Clear one or more filters